The news on Novo Nordisk
ShareThere has been 121 news on Novo Nordisk in the past from 16 different sources and amongst 4 sections.
Full access to all news in this scope:
See the trend on this scope:
Evolution through time
Latest news
Novo Nordisk Shares Surge on New Obesity Drug Results
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Novo Nordisk Annual Sales Jump on Demand for Ozempic and Wegovy
Novo Nordisk Earnings: Surge in Obesity Treatments Boosts Outlook
Obesity drug sales surge at Novo Nordisk
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Novo Nordisk Shares Still Have a Long Road Back from 40% Slump
Novo Nordisk shares jump up on latest weight-loss drug trial results
Novo Nordisk: New GLP-1 Drug Shows Leading Weight Loss in Small Trial
Novo Nordisk shares surge on results of new obesity drug trial
Novo Nordisk shares pop on early-stage weight loss drug trial results
Novo Nordisk: Shares Look Fairly Valued After CagriSema Disappointment
Novo Nordisk Stock Plunges After Disappointing Obesity Drug Data
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Novo Nordisk's drug stumble leaves it suddenly much slimmer
Novo Nordisk stock price takes a tumble after the Wegovy maker's next-generation weight-loss drug underwhelms
Novo Nordisk Stock Crashes After Disappointing Obesity Drug Data
Novo Nordisk Falls Most on Record After New Weight Drug Disappoints
Sections
The coverage spreads amongst 4 sections:
Sources
There has been 16 news sources reporting on this, including: CNBC News (25%), Quartz (21%), Financial Times (12%), The Wall Street Journal (12%), Morning Star (7%).
Going further
Stay up to date:
Details
This content can be used under the CC BY 4.0 license
